Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | DYNC1LI2 |
| Upstream (Parents) |
|---|
| (<<) BMPR2 → DYNC1LI2 |
| (<<) EFNB2 → DYNC1LI2 |
| (<<) EML4 → DYNC1LI2 |
| (<<) ENC1 → DYNC1LI2 |
| (<<) HIPK1 → DYNC1LI2 |
| (<<) KRAS → DYNC1LI2 |
| (<<) NFAT5 → DYNC1LI2 |
| (<<) NRIP1 → DYNC1LI2 |
| (<<) TNFRSF10A → DYNC1LI2 |
| Downstream (Children) |
|---|
| DYNC1LI2 → CAMKK2 (>>) |
| DYNC1LI2 → CASKIN1 (>>) |
| DYNC1LI2 → CCND1 (>>) |
| DYNC1LI2 → CDH24 (>>) |
| DYNC1LI2 → CDK6 (>>) |
| DYNC1LI2 → COIL (>>) |
| DYNC1LI2 → EGFR (>>) |
| DYNC1LI2 → EGR1 (>>) |
| DYNC1LI2 → EIF2C2 (>>) |
| DYNC1LI2 → EWSR1 (>>) |
| DYNC1LI2 → GRB10 (>>) |
| DYNC1LI2 → KLF7 (>>) |
| DYNC1LI2 → MAP1B (>>) |
| DYNC1LI2 → MAP3K3 (>>) |
| DYNC1LI2 → MAP3K5 (>>) |
| DYNC1LI2 → MOBKL2C (>>) |
| DYNC1LI2 → NFKBIZ (>>) |
| DYNC1LI2 → NRIP3 (>>) |
| DYNC1LI2 → PARP10 (>>) |
| DYNC1LI2 → PDPK1 (>>) |
| DYNC1LI2 → PINX1 (>>) |
| DYNC1LI2 → PPP2R5C (>>) |
| DYNC1LI2 → PRKCI (>>) |
| DYNC1LI2 → SLC20A1 (>>) |
| DYNC1LI2 → SYNJ2 (>>) |
| DYNC1LI2 → TUBA8 (>>) |
| DYNC1LI2 → TYRO3 (>>) |
| DYNC1LI2 → WBP4 (>>) |
